Home/Filings/4/0001493152-23-043892
4//SEC Filing

FASHEK CHRISTOPHER M 4

Accession 0001493152-23-043892

CIK 0001326706other

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 4:45 PM ET

Size

17.9 KB

Accession

0001493152-23-043892

Insider Transaction Report

Form 4
Period: 2023-11-15
Transactions
  • Award

    Option to Purchase Common Stock

    2023-11-15+14,00014,000 total
    Exercise: $1.24Exp: 2033-11-15Common Stock (14,000 underlying)
  • Disposition to Issuer

    Options to Purchase Common Stock

    2023-11-291,1250 total
    Exercise: $20.20Exp: 2028-08-14Common Stock (1,125 underlying)
  • Disposition to Issuer

    Options to Purchase Common Stock

    2023-11-292,1000 total
    Exercise: $41.40From: 2020-07-07Exp: 2030-07-07Common Stock (2,100 underlying)
  • Disposition to Issuer

    Options to Purchase Common Stock

    2023-11-292,5000 total
    Exercise: $14.40From: 2020-10-01Exp: 2030-10-01Common Stock (2,500 underlying)
  • Disposition to Issuer

    Options to Purchase Common Stock

    2023-11-296,0000 total
    Exercise: $16.80Exp: 2030-12-22Common Stock (6,000 underlying)
  • Disposition to Issuer

    Options to Purchase Common Stock

    2023-11-294,0000 total
    Exercise: $20.20Exp: 2031-12-28Common Stock (4,000 underlying)
Footnotes (5)
  • [F1]100% of the option vested on November 15, 2023, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.
  • [F2]The option vested in two equal installments as follows: (i) 1/2 of the total shares on November 1, 2018, and (ii) 1/2 of the total shares on November 1, 2019.
  • [F3]20% of the option vested on December 22, 2020 (the "2020 Date of Grant"), with an additional 20% vested on the three month anniversary of the 2020 Date of Grant, a further 20% vested on the six month anniversary of the 2020 Date of Grant, a further 20% vested on the nine month anniversary of the 2020 Date of Grant, and the final 20% vested on the year anniversary of the 2020 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.
  • [F4]25% of the option vested on December 29, 2021 (the "2021 Date of Grant"), with an additional 25% vested on the three-month anniversary of the 2021 Date of Grant, a further 25% vested on the six-month anniversary of the 2021 Date of Grant, and the final 25% vested on the nine-month anniversary of the 2021 Date of Grant, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.
  • [F5]The options were canceled by mutual agreement of the reporting person and NanoVibronix, Inc. The reporting person received $1.00 as the aggregate consideration for the cancellations.

Documents

1 file

Issuer

NanoVibronix, Inc.

CIK 0001326706

Entity typeother

Related Parties

1
  • filerCIK 0001279063

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:45 PM ET
Size
17.9 KB